MSU Drug Discovery

Toggle Accessibility Tools

NEWS

https://doi.org/10.1021/acschembio.8b00849

  • "Identification of New MmpL3 Inhibitors by Untargeted and Targeted Mutant Screens Defines MmpL3 Domains with Differential Resistance" Williams, et al., Antimicrobial Agents and Chemotherapy Sept. 2019

https://aac.asm.org/content/63/10/e00547-19.long

 

 

MSU DD Graphic

Upcoming Events

Sparty head logo
Due to the campus closure from Covid-19, all DD events are suspended until further notice

Services

ADDRC clickit

  • High throughput screening
  • Automated laboratory robotics
  • Hit selection

In vivo clickit

  • Efficacy testing in normal & disease models
  • Safety testing
  • Imaging
  • In vivo techical assistance
  • PK studies 

MCC

  • Active pharmaceutical ingredient development
  • Screening & target validation
  • Series identification & Scale-up

Welcome to Drug Discovery at Michigan State UniversityMSU DD General Pipeline


Other Resources Available:

Molecular Interaction ANalysis

pharmacokinetics

Consultation